Cardlytics
CDLX
156 hedge funds and large institutions have $1.45B invested in Cardlytics in 2019 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 48 increasing their positions, 43 reducing their positions, and 18 closing their positions.
217% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 18
175% more funds holding in top 10
Funds holding in top 10: 4 → 11 (+7)
103% more capital invested
Capital invested by funds: $712M → $1.45B (+$734M)
33% more funds holding
Funds holding: 117 → 156 (+39)
12% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 43
0.22% more ownership
Funds ownership: 8.73% → 8.95% (+0.22%)
48% less call options, than puts
Call options by funds: $1.45M | Put options by funds: $2.78M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
CAS Investment Partners
Westport,
Connecticut
|
+$24.6M |
| 2 |
Tiger Global Management
New York
|
+$22.3M |
| 3 |
D.E. Shaw & Co
New York
|
+$19.9M |
| 4 |
Bank of New York Mellon
New York
|
+$16.8M |
| 5 |
JCM
JS Capital Management
New York
|
+$16.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVMCV
Polaris Venture Management Co V
Boston,
Massachusetts
|
-$64M |
| 2 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$16.2M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$13.1M |
| 4 |
JP Morgan Chase
New York
|
-$12.6M |
| 5 |
Jennison Associates
New York
|
-$10.8M |
CDLX Hedge Fund Activity: Q4 2019 in Review
156 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q4 2019, worth a combined $1.45B — up 103% from $712M a quarter earlier.
Buyers outnumbered sellers: 57 funds opened new CDLX positions and 18 closed out — a net gain of 39 holders — while 48 added to existing stakes and 43 trimmed.
The largest buyer was CAS Investment Partners, adding an estimated $24.6M. The largest seller was Polaris Venture Management Co V, cutting an estimated $64M.
- 156 institutional investors held Cardlytics (CDLX) as of Q4 2019, up from 117 in Q3 2019.
- Funds reported $1.45B of Cardlytics stock for Q4 2019, up 103% quarter-over-quarter.
- 57 funds opened new Cardlytics positions in Q4 2019 and 18 closed out, a net change of +39 holders.
- The largest Cardlytics buyer in Q4 2019 was CAS Investment Partners, an estimated $24.6M added.
- The largest Cardlytics seller in Q4 2019 was Polaris Venture Management Co V, an estimated $64M sold.
Based on aggregated 13F filings for Q4 2019.